Stock Scorecard
Stock Summary for Verrica Pharmaceuticals Inc (VRCA) - $0.71 as of 7/4/2025 2:29:51 AM EST
Total Score
8 out of 30
Safety Score
15 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for VRCA
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for VRCA
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for VRCA
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for VRCA
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for VRCA (15 out of 100)
| Stock Price Rating (Max of 10) | 1 |
| Historical Stock Price Rating (Max of 10) | 4 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 5 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for VRCA
Financial Details for VRCA
Company Overview |
|
|---|---|
| Ticker | VRCA |
| Company Name | Verrica Pharmaceuticals Inc |
| Country | USA |
| Description | Verrica Pharmaceuticals Inc., a dermatological therapy company, develops and markets treatments for people with skin conditions in the United States. The company is headquartered in West Chester, Pennsylvania. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 0.71 |
| Price 4 Years Ago | 9.16 |
| Last Day Price Updated | 7/4/2025 2:29:51 AM EST |
| Last Day Volume | 484,602 |
| Average Daily Volume | 506,708 |
| 52-Week High | 8.98 |
| 52-Week Low | 0.38 |
| Last Price to 52 Week Low | 86.84% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 21.93 |
| Sector PE | 40.90 |
| 5-Year Average PE | -4.27 |
| Free Cash Flow Ratio | 2.22 |
| Industry Free Cash Flow Ratio | 17.71 |
| Sector Free Cash Flow Ratio | 32.91 |
| Current Ratio Most Recent Quarter | 1.34 |
| Total Cash Per Share | 0.32 |
| Book Value Per Share Most Recent Quarter | -0.20 |
| Price to Book Ratio | 238.54 |
| Industry Price to Book Ratio | 34.53 |
| Sector Price to Book Ratio | 30.76 |
| Price to Sales Ratio Twelve Trailing Months | 8.35 |
| Industry Price to Sales Ratio Twelve Trailing Months | 121.97 |
| Sector Price to Sales Ratio Twelve Trailing Months | 35.60 |
| Analyst Buy Ratings | 2 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 92,491,000 |
| Market Capitalization | 65,668,610 |
| Institutional Ownership | 31.90% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -14.31% |
| Reported EPS 12 Trailing Months | -1.14 |
| Reported EPS Past Year | -0.10 |
| Reported EPS Prior Year | -1.50 |
| Net Income Twelve Trailing Months | -65,990,000 |
| Net Income Past Year | -76,579,000 |
| Net Income Prior Year | -66,995,000 |
| Quarterly Revenue Growth YOY | -10.10% |
| 5-Year Revenue Growth | 0.00% |
| Operating Margin Twelve Trailing Months | -236.40% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 29,595,000 |
| Total Cash Past Year | 46,329,000 |
| Total Cash Prior Year | 69,547,000 |
| Net Cash Position Most Recent Quarter | 1,786,000 |
| Net Cash Position Past Year | 15,346,000 |
| Long Term Debt Past Year | 30,983,000 |
| Long Term Debt Prior Year | 42,874,000 |
| Total Debt Most Recent Quarter | 27,809,000 |
| Equity to Debt Ratio Past Year | -0.47 |
| Equity to Debt Ratio Most Recent Quarter | -2.01 |
| Total Stockholder Equity Past Year | -9,860,000 |
| Total Stockholder Equity Prior Year | 19,763,000 |
| Total Stockholder Equity Most Recent Quarter | -18,576,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -53,684,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.58 |
| Free Cash Flow Past Year | -60,954,000 |
| Free Cash Flow Prior Year | -38,939,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.02 |
| MACD Signal | 0.02 |
| 20-Day Bollinger Lower Band | 0.39 |
| 20-Day Bollinger Middle Band | 0.57 |
| 20-Day Bollinger Upper Band | 0.74 |
| Beta | 1.76 |
| RSI | 50.70 |
| 50-Day SMA | 1.56 |
| 150-Day SMA | 4.00 |
| 200-Day SMA | 5.02 |
System |
|
| Modified | 7/3/2025 1:36:23 PM EST |